Cargando…

Immunization of mice by a multimeric L2-based linear epitope (17-36) from HPV type 16/18 induced cross reactive neutralizing antibodies

Current licensed and commercially available prophylactic human papillomavirus (HPV) vaccines (Cervarix and quadrivalent/nine valents Gardasil) are based on major capsid protein L1 virus-like particles (VLPs) production which are expensive and type specific. Minor capsid L2-RG1 linear epitope (17-36)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khiavi, Farhad Motavalli, Arashkia, Arash, Nasimi, Maryam, Mahdavi, Mehdi, Golkar, Majid, Roohvand, Farzin, Azadmanesh, Kayhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566000/ https://www.ncbi.nlm.nih.gov/pubmed/28855937 http://dx.doi.org/10.4103/1735-5362.212043

Ejemplares similares

A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice
por: Motavalli Khiavi, Farhad, et al.
Publicado: (2018)

Isolation, cloning, and expression of E. coli BirA gene for biotinylation applications
por: Etemadzadeh, Mohammad Hossein, et al.
Publicado: (2015)

Adenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses
por: Shoushtari, Mohammad, et al.
Publicado: (2022)

Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope
por: Mashhadi Abolghasem Shirazi, Maryam, et al.
Publicado: (2023)

Expression of a biotin acceptor peptide-containing protein with potential incorporation on the lentiviral envelope as a viral surface engineering platform
por: Etemadzadeh, Mohammad Hossein, et al.
Publicado: (2015)

Modifying oncolytic virotherapy to overcome the barrier of the hypoxic tumor microenvironment. Where do we stand?
por: Shayan, Sara, et al.
Publicado: (2022)

In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines
por: Shayan, Sara, et al.
Publicado: (2023)

IFN-α(2b) reduces released particles of Human T-lymphotropic Virus-I from HTLV-I transformed cell line
por: Hartoonian, Christine, et al.
Publicado: (2011)

The β‐domain of streptokinase affects several functionalities, including specific/proteolytic activity kinetics
por: Rafipour, Maryam, et al.
Publicado: (2019)

Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic/Proteolytic Activities and Fibrin-Dependent Plasminogen Activation: A Domain-Exchange Study
por: Rafipour, Maryam, et al.
Publicado: (2020)

Construction of Various γ34.5 Deleted Fluorescent-Expressing Oncolytic herpes Simplex type 1 (oHSV) for Generation and Isolation of HSV-Based Vectors
por: Abdoli, Shahriyar, et al.
Publicado: (2017)

Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia
por: Shayan, Sara, et al.
Publicado: (2022)

Fiber manipulation and post-assembly nanobody conjugation for adenoviral vector retargeting through SpyTag-SpyCatcher protein ligation
por: Kadkhodazadeh, Maryam, et al.
Publicado: (2022)

Co‐administration of 2’3’-cGAMP STING activator and CpG-C adjuvants with a mutated form of HPV 16 E7 protein leads to tumor growth inhibition in the mouse model
por: Dorostkar, Fariba, et al.
Publicado: (2021)

The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options
por: Beig Parikhani, Arezoo, et al.
Publicado: (2021)

The immunodominant and neutralization linear epitopes for SARS-CoV-2
por: Lu, Shuai, et al.
Publicado: (2021)

Streptokinase for Treatment of Thrombotic Disorders: The End? Or the End of the Beginning?
por: Roohvand, Farzin
Publicado: (2018)

Precise location of linear epitopes on the capsid surface of feline calicivirus recognized by neutralizing and non-neutralizing monoclonal antibodies
por: Cubillos-Zapata, Carolina, et al.
Publicado: (2020)

Evaluation of cellular responses for a chimeric HBsAg-HCV core DNA vaccine in BALB/c mice
por: Yazdanian, Maryam, et al.
Publicado: (2015)

Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus
por: Jin, Zhongyuan, et al.
Publicado: (2021)

Enhanced immune responses to viral epitopes by combining macrophage-inducible expression with multimeric display on a Salmonella vector
por: Chen, Huaiqing, et al.
Publicado: (2001)

Immunization of Mice by BCG Formulated HCV Core Protein Elicited Higher Th1-Oriented Responses Compared to Pluronic-F127 Copolymer
por: Yazdanian, Maryam, et al.
Publicado: (2013)

Identification and Validation of a Linear Protective Neutralizing Epitope in the β-Pore Domain of Alpha Toxin
por: Oscherwitz, Jon, et al.
Publicado: (2015)

Identification of a neutralizing linear epitope within the VP1 protein of coxsackievirus A10
por: Zhu, Hanyu, et al.
Publicado: (2022)

Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2
por: Bianchini, Filippo, et al.
Publicado: (2022)

Multimerization rules for G-quadruplexes
por: Kolesnikova, Sofia, et al.
Publicado: (2017)

Demonstration of a Simple Epitope Tag Multimerization Strategy for Enhancing the Sensitivity of Protein Detection Using Drosophila vAChT
por: Tison, Kole V., et al.
Publicado: (2019)

The pneumococcal MgaSpn virulence transcriptional regulator generates multimeric complexes on linear double-stranded DNA
por: Solano-Collado, Virtu, et al.
Publicado: (2013)

Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice
por: Li, Yue-Xiang, et al.
Publicado: (2014)

Multimerization of Ebola GPΔmucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies
por: Powell, Abigail E., et al.
Publicado: (2022)

Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein
por: Chukwudozie, Onyeka S., et al.
Publicado: (2021)

BacMam virus-based surface display for HCV E2 glycoprotein induces strong cross-neutralizing antibodies and cellular immune responses in vaccinated mice
por: Kord, Ebrahim, et al.
Publicado: (2021)

Breaking symmetry in multimeric ATPase motors
por: Sysoeva, Tatyana A, et al.
Publicado: (2014)

Structure and Function of Multimeric G-Quadruplexes
por: Kolesnikova, Sofia, et al.
Publicado: (2019)

Multimerization variants as potential drivers of neofunctionalization
por: Lee, Youngwoo, et al.
Publicado: (2021)

Detection of Specific RNA Targets by Multimerization
por: Sakhabutdinova, Assol R., et al.
Publicado: (2023)

Enhanced-Transient Expression of Hepatitis C Virus Core Protein in Nicotiana tabacum, a Protein With Potential Clinical Applications
por: Mohammadzadeh, Sara, et al.
Publicado: (2014)

A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
por: Tumban, Ebenezer, et al.
Publicado: (2011)

Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes
por: Gu, Jun, et al.
Publicado: (2018)

Characterization of an Isotype-Dependent Monoclonal Antibody against Linear Neutralizing Epitope Effective for Prophylaxis of Enterovirus 71 Infection
por: Lim, Xiao Fang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ttojqdbqkbm0ipokstpbu5qj98